Inovio Pharmaceuticals Inc (NASDAQ:INO) shares are trading lower Tuesday after the company announced the pricing of a public offering.
What Happened: Inovio announced the pricing of an underwritten offering of 2,536,258 shares of its common stock at an offering price of $7.693 per share. The company will also offer pre-funded warrants to purchase 2,135,477 shares of its common stock at an offering price of $7.692 per pre-funded warrant.
All of the securities are being offered and sold by Inovio. The offering is expected to close on or about April 18. Inovio said it anticipates gross proceeds of approximately $36 million.
Inovio is a biotechnology company focused on developing and commercializing DNA medicines ...